Kyverna Therapeutics (KYTX) Change in Acquisitions & Divestments (2023 - 2026)

Kyverna Therapeutics (KYTX) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $65.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 24.22% year-over-year to $65.7 million; the trailing twelve-month figure through Mar 2026 stood at $384.7 million (down 2.61% YoY), and the FY2025 full-year result was $405.7 million, up 22.46% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $65.7 million, down from $99.2 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $157.0 million in Q4 2024 and bottomed at $13.0 million in Q2 2024.
• The 4-year median for Change in Acquisitions & Divestments is $86.7 million (2025), against an average of $77.2 million.
• Peak annual rise in Change in Acquisitions & Divestments reached 854.62% in 2025, while the deepest fall reached 36.81% in 2025.
• A 4-year view of Change in Acquisitions & Divestments shows it stood at $33.0 million in 2023, then surged by 375.76% to $157.0 million in 2024, then tumbled by 36.81% to $99.2 million in 2025, then sank by 33.77% to $65.7 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $65.7 million (Q1 2026), $99.2 million (Q4 2025), and $95.7 million (Q3 2025), per Business Quant data.

Peer Comparison